Adrian Goldiș

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Séverine Vermeire, Stefan Schreiber, Robert Petryka et al. · The Lancet · 2016 · 439 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study

Johan Burisch, Hillel Vardi, Doron Schwartz et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 162 citations · Full text

Medicine, Health Sciences, Clinical Epidemiology +11

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Strategies to manage hepatitis C virus infection disease burden – volume 3

N. Nugrahini, Mojca Matičič, Ieva Tolmane et al. · Journal of Viral Hepatitis · 2015 · 93 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +16

Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania

Cristian Gheorghe, Oliviu Pascu, Liana Gheorghe et al. · European Journal of Gastroenterology & Hepatology · 2004 · 92 citations

Medicine, Clinical Sciences, Internal Medicine +16